Anti-RNP (anti-U1-RNP) antibody
An autoantibody found in several connective-tissue diseases. Its standout role is that a high level, together with typical features like Raynaud's and puffy fingers, defines mixed connective-tissue disease — an overlap condition. It is also seen in lupus, so results are read in context.
What it measures
Anti-RNP (more precisely anti-U1-RNP) is an autoantibody against a ribonucleoprotein complex inside cells, and one of the extractable nuclear antigen (ENA) antibodies checked after a positive ANA. It appears in several connective-tissue diseases, but its most distinctive and clinically useful role is in mixed connective-tissue disease (MCTD): a high-titre anti-U1-RNP is effectively the defining laboratory feature, and MCTD is characterised by an 'overlap' of features from lupus, systemic sclerosis and inflammatory muscle disease — classically Raynaud's phenomenon, puffy (swollen) fingers, joint pains and muscle weakness. Anti-RNP is also found in lupus (where it can be part of the antibody profile alongside others), and at lower levels in other conditions. The level matters: a high titre with the right clinical picture points strongly to MCTD, while a low-level positive is less specific. As with all autoantibodies, anti-RNP is interpreted together with the ANA pattern, the other ENA antibodies and — most importantly — the person's actual symptoms and examination, by a rheumatologist.
What a high value can mean
- Mixed connective-tissue disease (MCTD) — a high titre is the hallmark, with Raynaud's, puffy fingers, joint and muscle symptoms.
- Lupus — commonly part of the antibody profile.
- Overlap connective-tissue disease — features spanning lupus, scleroderma and myositis.
- A low-level positive — less specific, interpreted with the clinical picture.
What a low value can mean
- Negative — the expected result; makes MCTD unlikely and removes one antibody from the connective-tissue work-up.
When to discuss with a doctor
Anti-RNP is tested when a connective-tissue disease is suspected — particularly when there is an overlap of features such as Raynaud's phenomenon, puffy fingers, joint pains and muscle weakness with a positive ANA. A high-titre anti-U1-RNP, together with that clinical picture, points to mixed connective-tissue disease, but the diagnosis is made by a rheumatologist using the whole picture, not the antibody alone. A positive result also occurs in lupus and is read alongside the other antibodies. Mediora.AI can surface a positive anti-RNP alongside ANA and anti-dsDNA so the overlap pattern is visible in your results, but distinguishing MCTD from lupus or another connective-tissue disease, and deciding on treatment, belongs with your doctor and rheumatologist.